Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

At the 2016 NCRI Cancer Conference, the latest basic, translational and clinical cancer research will be presented and discussed.

The program covers six main themes, which are diagnosis and therapy, epidemiology and prevention, healthcare delivery, information, patients and the public supportive, palliative care, survivorship, as well as cancer cell and model systems.

NCRI 2016

06–09 November 2016 | The BT Convention Centre, Liverpool

NCRI 2016

06–09 November 2016 | The BT Convention Centre, Liverpool

At the 2016 NCRI Cancer Conference, the latest basic, translational and clinical cancer research will be presented and discussed.

The program covers six main themes, which are diagnosis and therapy, epidemiology and prevention, healthcare delivery, information, patients and the public supportive, palliative care, survivorship, as well as cancer cell and model systems.

Targeting apoptosis – developing drugs to inhibit Bcl-2 and Mcl-1 1:10
Targeting apoptosis – developing drugs to inhibit Bcl-2 and Mcl-1
Andreas Strasser • 6 Nov 2016
Challenges with drug combinations 1:05
Challenges with drug combinations
Andreas Strasser • 6 Nov 2016
Identifying human cancers to target with BCL-2 inhibition 2:36
Identifying human cancers to target with BCL-2 inhibition
Anthony Letai • 6 Nov 2016
Microenvironment role in AML: talk overview 1:02
Microenvironment role in AML: talk overview
Dominique Bonnet • 6 Nov 2016
The use of the process of apoptosis for cancer treatments 1:13
The use of the process of apoptosis for cancer treatments
Andreas Strasser • 6 Nov 2016
The content of VJHemOnc is intended for healthcare professionals